Sarepta therapeutics to showcase data from its gene therapy and rna platforms at world muscle society 2021 virtual congress

Cambridge, mass., sept. 14, 2021 (globe newswire) -- sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, will present at the world muscle society 2021 virtual congress (wms 2021), taking place sept. 20-24, 2021. this year's presentations at wms 2021 highlight scientific leadership and innovation from across sarepta's deep, multi-platform portfolio and reflect the company's continued commitment advancing life-changing therapies to those with rare genetic diseases.
SRPT Ratings Summary
SRPT Quant Ranking